ES2113040T3 - Procedimiento de un solo recipiente para la fabricacion de derivados del acido 3-quinoloncarboxilico. - Google Patents

Procedimiento de un solo recipiente para la fabricacion de derivados del acido 3-quinoloncarboxilico.

Info

Publication number
ES2113040T3
ES2113040T3 ES94118676T ES94118676T ES2113040T3 ES 2113040 T3 ES2113040 T3 ES 2113040T3 ES 94118676 T ES94118676 T ES 94118676T ES 94118676 T ES94118676 T ES 94118676T ES 2113040 T3 ES2113040 T3 ES 2113040T3
Authority
ES
Spain
Prior art keywords
chinoloncarboxylic
procedure
manufacture
acid derivatives
single container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94118676T
Other languages
English (en)
Inventor
Rudolf Dr Zerbes
Paul Dr Naab
Gerhard Dr Franckowiak
Herbert Dr Diehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2113040T3 publication Critical patent/ES2113040T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCESO UNICO PARA LA ELABORACION DE DERIVADOS 7 - HETEROCICLIL - SUSTITUIDO 3 ACIDO CARBOXILICO QUINOLONA. TIENEN UN EFECTO ANTIMICROBIAL INTENSO. A ELLOS PERTENECEN SUSTANCIAS ACTIVAS COMO POR EJEMPLO OFLOXACINA, CIPROFLOXACINA O ENROFLOXACINA.
ES94118676T 1993-12-10 1994-11-28 Procedimiento de un solo recipiente para la fabricacion de derivados del acido 3-quinoloncarboxilico. Expired - Lifetime ES2113040T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342186A DE4342186A1 (de) 1993-12-10 1993-12-10 Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten

Publications (1)

Publication Number Publication Date
ES2113040T3 true ES2113040T3 (es) 1998-04-16

Family

ID=6504693

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94118676T Expired - Lifetime ES2113040T3 (es) 1993-12-10 1994-11-28 Procedimiento de un solo recipiente para la fabricacion de derivados del acido 3-quinoloncarboxilico.

Country Status (35)

Country Link
US (1) US5639886A (es)
EP (1) EP0657448B1 (es)
JP (1) JP3963490B2 (es)
KR (1) KR950018008A (es)
CN (1) CN1109877A (es)
AT (1) ATE163645T1 (es)
AU (1) AU693818B2 (es)
BG (1) BG61947B1 (es)
CA (1) CA2137523C (es)
CO (1) CO4180607A1 (es)
CZ (1) CZ288078B6 (es)
DE (2) DE4342186A1 (es)
DK (1) DK0657448T3 (es)
EE (1) EE03215B1 (es)
ES (1) ES2113040T3 (es)
FI (1) FI945776A (es)
GR (1) GR3026383T3 (es)
HR (1) HRP940950B1 (es)
HU (1) HU220597B1 (es)
IL (1) IL111921A (es)
LV (1) LV11470B (es)
MY (1) MY113302A (es)
NO (1) NO307180B1 (es)
NZ (1) NZ270086A (es)
PE (1) PE33795A1 (es)
PL (1) PL180022B1 (es)
RO (1) RO113345B1 (es)
RU (1) RU2138483C1 (es)
SI (1) SI0657448T1 (es)
SK (1) SK279950B6 (es)
SV (1) SV1994000071A (es)
TW (1) TW401412B (es)
UA (1) UA41323C2 (es)
YU (1) YU48865B (es)
ZA (1) ZA949830B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826050A1 (de) * 1998-06-12 1999-12-16 Bayer Ag Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester
WO2001062734A1 (fr) * 2000-02-25 2001-08-30 Daiichi Pharmaceutical Co., Ltd. Procede de production d'acides quinolonecarboxyliques et de leurs intermediaires
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
DE10026903A1 (de) * 2000-06-03 2002-01-10 Cpc Cellular Process Chemistry Verfahren zur Herstellung von Chinolon-3-carbonsäuren
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
WO2003099815A1 (en) 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
AU2003304460A1 (en) * 2003-09-04 2005-03-29 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
CN100412075C (zh) * 2004-06-22 2008-08-20 浙江医药股份有限公司新昌制药厂 左旋氧氟沙星和氧氟沙星的制备方法
EP2089388B1 (en) 2006-11-13 2014-01-29 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
FR2916446B1 (fr) * 2007-05-24 2009-08-21 Biocodex Sa Nouveau procede de synthese de fluoroquinolones
EP2083010A1 (en) 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
CN101781299B (zh) * 2010-01-13 2012-06-27 杭州师范大学 一种喹诺酮类药物关键中间体的一锅法合成方法
IT1398952B1 (it) * 2010-03-19 2013-03-28 F S I Fabbrica Italiana Sint Processo di preparazione della moxifloxacina e suoi sali
CN102675306A (zh) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 一种莫西沙星或其盐的制备方法
CN102267994B (zh) * 2011-06-17 2013-01-30 江苏正大丰海制药有限公司 一种盐酸莫西沙星已知杂质的制备方法
WO2013157018A1 (en) 2012-04-18 2013-10-24 Indian Institute Of Technology Madras A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
UA106556C2 (uk) 2013-05-13 2014-09-10 Наталья Николаевна Деркач СПОСІБ ОДЕРЖАННЯ (1-ЦИКЛОПРОПІЛ-6-ФТОР-1,4-ДИГІДРО-8-МЕТОКСІ-7-[(4aS,7aS)-ОКТАГІДРО-6Н-ПІРОЛО[3,4-b]-4-ОКСО-3-ХІНОЛІНКАРБОНОВОЇ КИСЛОТИ
EP3638648A4 (en) 2017-06-12 2021-02-17 Virginia Commonwealth University STREAMLINED SYNTHESES OF FLUORCHINOLONES
CN115385856A (zh) * 2022-09-05 2022-11-25 常州大学 一锅法合成诺氟沙星中间体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPS63179856A (ja) 1987-01-21 1988-07-23 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法並びにその中間体
DE3724466A1 (de) 1987-07-24 1989-02-02 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeuren
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE4208792A1 (de) 1992-03-19 1993-09-23 Bayer Ag Enantiomerenreine chinolincarbonsaeure-derivate
TW209865B (es) * 1992-01-10 1993-07-21 Bayer Ag
DE4208789A1 (de) 1992-03-19 1993-09-23 Bayer Ag Enantiomerenreine chinolincarbonsaeure-derivate
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
JP2758722B2 (ja) * 1993-08-13 1998-05-28 ドング ホワ ファーマシューチカル インダストリアル カンパニー，リミテッド 新規キノロンカルボン酸誘導体

Also Published As

Publication number Publication date
TW401412B (en) 2000-08-11
HRP940950B1 (en) 1998-12-31
RU94043645A (ru) 1996-10-27
ZA949830B (en) 1995-08-22
RU2138483C1 (ru) 1999-09-27
FI945776A (fi) 1995-06-11
IL111921A (en) 1999-07-14
SV1994000071A (es) 1995-07-29
LV11470A (lv) 1996-08-20
CZ288078B6 (cs) 2001-04-11
CZ310594A3 (en) 1995-09-13
ATE163645T1 (de) 1998-03-15
DE59405376D1 (de) 1998-04-09
SI0657448T1 (en) 1998-06-30
US5639886A (en) 1997-06-17
AU693818B2 (en) 1998-07-09
FI945776A0 (fi) 1994-12-08
CA2137523A1 (en) 1995-06-11
CA2137523C (en) 2007-05-22
NO307180B1 (no) 2000-02-21
HRP940950A2 (en) 1997-02-28
LV11470B (en) 1996-12-20
DE4342186A1 (de) 1995-06-14
SK151494A3 (en) 1995-07-11
BG61947B1 (bg) 1998-10-30
CN1109877A (zh) 1995-10-11
EE03215B1 (et) 1999-08-16
PE33795A1 (es) 1995-12-15
YU71694A (sh) 1996-10-18
AU8024494A (en) 1995-06-15
NO944786L (no) 1995-06-12
UA41323C2 (uk) 2001-09-17
DK0657448T3 (da) 1998-12-21
HUT72058A (en) 1996-03-28
EP0657448B1 (de) 1998-03-04
YU48865B (sh) 2002-08-12
SK279950B6 (sk) 1999-06-11
KR950018008A (ko) 1995-07-22
RO113345B1 (ro) 1998-06-30
JPH07196621A (ja) 1995-08-01
PL180022B1 (pl) 2000-12-29
CO4180607A1 (es) 1995-06-07
EP0657448A1 (de) 1995-06-14
JP3963490B2 (ja) 2007-08-22
IL111921A0 (en) 1995-03-15
GR3026383T3 (en) 1998-06-30
HU9403553D0 (en) 1995-02-28
HU220597B1 (hu) 2002-03-28
PL306198A1 (en) 1995-06-12
BG99248A (en) 1995-09-29
MY113302A (en) 2002-01-31
NO944786D0 (no) 1994-12-09
NZ270086A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
ES2113040T3 (es) Procedimiento de un solo recipiente para la fabricacion de derivados del acido 3-quinoloncarboxilico.
HUT67653A (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
WO2000047568A3 (en) 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
AU6522090A (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
PT1274698E (pt) Perciquinina, metodo para a sua producao e sua utilizacao como medicamento
MA20322A1 (fr) Nouveaux derives de n-(4-piperidinyl)-bicyclo condenses 2-imidozolamine et procede pour leur preparation
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
MX9204110A (es) Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.
AU5059690A (en) (3-(c16-c18)-alkanesulphinyl- and sulphonyl-2-methoxy-methyl-propyl)-(2-trimethylammonioethyl) phosphates, processes for the preparation thereof and pharmaceutical compositions containing them
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
BR0112245A (pt) éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxìlico e processo para sua preparação
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
FI964918A0 (fi) Lääkeainesuoloja
ES2074257T3 (es) Derivados de aminoacidos.
ATE117202T1 (de) Vitamin enthaltende formulierungen und deren herstellung.
ITMI950132A1 (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ATE306273T1 (de) Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose
IT1263913B (it) Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
WO2000046193A3 (en) Ether derivatives having neuronal activity
DE3464601D1 (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles, process for their preparation and medicines with anti-thrombotic effects containing them
MX6526A (es) Procedimiento para la preparacion de aminoacido insaturados, producto obtenido y composicion farmaceutica util como anticonvulsivo.
MX9606291A (es) Derivados de aminoacidos y su empleo como agentes pesticidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 657448

Country of ref document: ES